Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastric Cancer Peritoneal Metastases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT02840331
What this trial is testing

Pilot Study on Intra-abdominal Photodynamic Diagnosis in Peritoneal Carcinosis

Who this might be right for
Peritoneal Carcinomatosis
University Hospital Tuebingen 50
Early research (Phase 1)Looking for participantsNCT06675136
What this trial is testing

Nab-Paclitaxel PIPAC in Combination With Paclitaxel and Ramucirumab for the Treatment of Stomach Cancer With Peritoneal Metastases

Who this might be right for
Clinical Stage IVB Gastric Cancer AJCC v8Metastatic Gastric AdenocarcinomaMetastatic Malignant Neoplasm in the Peritoneum
City of Hope Medical Center 30
Not applicableNot Yet RecruitingNCT05661110
What this trial is testing

Biomarker Analysis of HIPEC Combined With PD1/PDL1 Inhibitor for Gastric Cancer With Peritoneal Metastasis

Who this might be right for
Gastric Cancer
Affiliated Cancer Hospital & Institute of Guangzhou Medical University 46
Testing effectiveness (Phase 2)UnknownNCT05497739
What this trial is testing

Intraperitoneal Chemotherapy Guided by the Detection of DNA in Peritoneal Lavage Fluid in Patients With Gastric Cancer

Who this might be right for
Gastric Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 68
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07304258
What this trial is testing

A Prospective, Phase II Clinical Study of HIPEC Combined With NIPS and Tislelizumab Conversion Therapy for Gastric Cancer With Peritoneal Metastasis With Positive Cytology Alone or PCI Score ≤10

Who this might be right for
Gastric Cancer Peritoneal Metastases
Hebei Medical University 30
Testing effectiveness (Phase 2)Looking for participantsNCT06519591
What this trial is testing

Systemic Application of Cadonilimab, LM-302, and S-1 Combined With Intraperitoneal Infusion of Paclitaxel for the Treatment of Claudin 18.2-positive Gastric Cancer With Peritoneal Metastasis

Who this might be right for
Gastric Cancer Stage IVPeritoneal Metastases
Ruijin Hospital 40
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06295094
What this trial is testing

The Efficacy of PIPAC and Minimally Invasive Radical Resection in High-risk Gastric Cancer Patients.

Who this might be right for
Gastric CancerChemotherapy, AdjuvantPeritoneal Metastases+1 more
Odense University Hospital 264
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07486310
What this trial is testing

Evaluation of Pressurized Intraperitoneal Aerosol Chemotherapy With VRT106 Versus PIPAC in Patients With Advanced Gastric Cancer and PeritonealMetastasis: A Prospective, Multicenter, Open-Label, Randomized Controlled Trial

Who this might be right for
Advanced Gastric Cancer
Guangdong Provincial People's Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT04107077
What this trial is testing

Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer

Who this might be right for
Gastric CancerPeritoneal Carcinomatosis
University of Chicago 21
Testing effectiveness (Phase 2)UnknownNCT04155671
What this trial is testing

POF Versus FOLFOX Plus IP Paclitaxel in AGC

Who this might be right for
Gastric Cancer
Fujian Cancer Hospital 260
Early research (Phase 1)UnknownNCT04913662
What this trial is testing

Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Using Paclitaxel in Gastric Cancer Patients With Peritoneal Metastasis

Who this might be right for
Stomach NeoplasmPeritoneal Metastases
Seoul National University Bundang Hospital 18
Not applicableNot Yet RecruitingNCT06682182
What this trial is testing

Tislelizumab Combined with SOX and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Gastric Cancer with Peritoneal Metastasis: a Prospective Cohort Study

Who this might be right for
Gastric Cancer with Peritoneal Metastasis
Southwest Hospital, China 74
Not applicableNot Yet RecruitingNCT06858644
What this trial is testing

Development of a Predictive Model for Gastric Cancer Peritoneal Metastasis and Cachexia Using BUB1 and Radiopathomics Data With Deep Learning

Who this might be right for
Gastric (Stomach) Cancer
Qun Zhao 500
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07784413
What this trial is testing

A Sequential Trial of Low-Dose Radiotherapy Followed by Concurrent Immunotherapy, Systemic Chemotherapy, and Intraperitoneal Perfusion in Gastric Cancer With Peritoneal Carcinomatosis

Who this might be right for
Gastric Cancer Peritoneal Metastasis (GCPM)
Zhejiang Cancer Hospital 40
Testing effectiveness (Phase 2)Looking for participantsNCT07556640
What this trial is testing

LM-302 and S-1 Plus Intraperitoneal Paclitaxel With or Without Cadonilimab for Claudin 18.2-positive Gastric or Gastroesophageal Junction Adenocarcinoma With Peritoneal Metastasis: a Prospective, Exploratory Study

Who this might be right for
Gastric Cancer Stage IVPeritoneal Metastases From Gastric CancerGastric or Esophagogastric Junction Adenocarcinoma
Ruijin Hospital 74
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Not applicableUnknownNCT04889768
What this trial is testing

HIPEC Combined With Camrelizumab, Paclitaxel and S-1 for Conversion Therapy in Patients With Advanced Gastric Cancer With Peritoneal Metastasis

Who this might be right for
Gastric Cancer, HIPEC, Anti-PD-1 Antibody Camrelizumab (SHR-1210), Chemotherapy and Surgery
Zhejiang Cancer Hospital 46
Testing effectiveness (Phase 2)Ended earlyNCT04034251
What this trial is testing

Intraperitoneal and Intravenous Paclitaxel Chemotherapy With Oral Capecitabine for Gastric Adenocarcinoma With Peritoneal Carcinomatosis

Who this might be right for
Gastric AdenocarcinomaGastric CancerEsophagogastric Junction+1 more
National Cancer Institute (NCI) 12
Early research (Phase 1)Looking for participantsNCT07277413
What this trial is testing

IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

Who this might be right for
NSCLC AdenocarcinomaGastroesophageal Cancer (GC)Gastric Adenocarcinoma+10 more
IDEAYA Biosciences 260
Next Page